Benjamin J. del Tito

Nessuna posizione attualmente

68 anni

Health Technology

Consumer Services

Communications

Profilo

Dr. Benjamin J.
del Tito, Jr. PhD, is EVP-Regulatory Affairs & Project Management at Auxilium Pharmaceuticals, Inc. Dr. del Tito was previously employed as Vice President-Analytical & QC Operations by Neose Technologies, Inc., Senior Director-QC Operations by Medimmune Vaccines, Inc., and a Director-Biotechnology & Microbiology by AAI, Inc. He received his undergraduate degree from Millersville University, a graduate degree from the University of Western Kentucky, and a doctorate degree from Lehigh University.

Precedenti posizioni note di Benjamin J. del Tito

Società	Posizione	Fine
Neose Technologies, Inc. Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market.	Corporate Officer/Principal	01/01/2005
MedImmune Vaccines, Inc. MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA	Corporate Officer/Principal	01/01/2003
AAI, Inc. AAI, Inc. Specialty TelecommunicationsCommunications Part of TIS, Inc. (Japan), AAI, Inc. is an internet service provider. The private company is based in Tokyo, Japan.	Corporate Officer/Principal	01/01/1999
AUXILIUM PHARMACEUTICALS, INC.	General Counsel	-

Vedi nel dettaglio l'esperienza di Benjamin J. del Tito

Formazione di Benjamin J. del Tito

Lehigh University	Doctorate Degree
Millersville University	Undergraduate Degree
University of Western Kentucky	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Benjamin J. del Tito

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	4
Neose Technologies, Inc. Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market.	Health Technology
MedImmune Vaccines, Inc. MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA	Health Technology
Auxilium Pharmaceuticals LLC Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA.	Health Technology
AAI, Inc. AAI, Inc. Specialty TelecommunicationsCommunications Part of TIS, Inc. (Japan), AAI, Inc. is an internet service provider. The private company is based in Tokyo, Japan.	Communications

Vedi le connessioni aziendali